Alpha Cure Therapeutics

  • Biotech or pharma, therapeutic R&D

Alpha Cure Therapeutics is developing precision safe (non-radioactive) radioligand therapy via small molecule next-generation BNCT. 

We aim to cure Breast Cancer, including Triple Negative Breast Cancer (and other cancers)

Our technology is unique in the precision intracellular targeting of clinically validated mutant cancer proteins. A bimodal approach of BNCT alpha particle therapy and targeted pathway therapy.

Address

Lynnfield
Massachusetts
United States

Website

https://alphacuretx.com/

Contact Exhibitor


Loading
View all Partnering Companies

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS